# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-039338
Filing Date
2017-07-31
Accepted
2017-07-31 17:06:02
Documents
7
Period of Report
2017-09-21
Effectiveness Date
2017-07-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | v471599_def14a.htm | DEF 14A | 447160
2 | GRAPHIC | line.gif | GRAPHIC | 43
3 | GRAPHIC | logo_apollomed.jpg | GRAPHIC | 66869
4 | GRAPHIC | sig_warren-hosseinion.jpg | GRAPHIC | 19203
5 | GRAPHIC | spacer.gif | GRAPHIC | 43
6 | GRAPHIC | v471599_pc1.jpg | GRAPHIC | 864988
7 | GRAPHIC | v471599_pc2.jpg | GRAPHIC | 344839
| Complete submission text file | 0001144204-17-039338.txt |  | 2233359

Mailing Address 700 NORTH BRAND BLVD., SUITE 1400 GLENDALE CA 91203
Business Address 450 NORTH BRAND BLVD., SUITE 600 GLENDALE CA 91203 818-396-8050
Apollo Medical Holdings, Inc. (Filer) CIK: 0001083446 (see all company filings)

EIN.: 870042699 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37392 | Film No.: 17993691
SIC: 8742 Services-Management Consulting Services